IBDEI0PY ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12751,1,2,0)
 ;;=2^COAGULATION DEFECTS
 ;;^UTILITY(U,$J,358.3,12751,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,12752,0)
 ;;=156.9^^75^791^17
 ;;^UTILITY(U,$J,358.3,12752,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12752,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,12752,1,2,0)
 ;;=2^GALLBLADDER CANCER
 ;;^UTILITY(U,$J,358.3,12752,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,12753,0)
 ;;=459.0^^75^791^19
 ;;^UTILITY(U,$J,358.3,12753,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12753,1,1,0)
 ;;=1^459.0
 ;;^UTILITY(U,$J,358.3,12753,1,2,0)
 ;;=2^HEMORRHAGE NOS
 ;;^UTILITY(U,$J,358.3,12753,2)
 ;;=^55877
 ;;^UTILITY(U,$J,358.3,12754,0)
 ;;=176.9^^75^791^20
 ;;^UTILITY(U,$J,358.3,12754,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12754,1,1,0)
 ;;=1^176.9
 ;;^UTILITY(U,$J,358.3,12754,1,2,0)
 ;;=2^KAPOSI'S SARCOMA, NOS
 ;;^UTILITY(U,$J,358.3,12754,2)
 ;;=^107993
 ;;^UTILITY(U,$J,358.3,12755,0)
 ;;=161.9^^75^791^21
 ;;^UTILITY(U,$J,358.3,12755,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12755,1,1,0)
 ;;=1^161.9
 ;;^UTILITY(U,$J,358.3,12755,1,2,0)
 ;;=2^LARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,12755,2)
 ;;=^267128
 ;;^UTILITY(U,$J,358.3,12756,0)
 ;;=208.90^^75^791^22
 ;;^UTILITY(U,$J,358.3,12756,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12756,1,1,0)
 ;;=1^208.90
 ;;^UTILITY(U,$J,358.3,12756,1,2,0)
 ;;=2^LEUKEMIA,UNSP CELL TYPE
 ;;^UTILITY(U,$J,358.3,12756,2)
 ;;=^336874
 ;;^UTILITY(U,$J,358.3,12757,0)
 ;;=140.9^^75^791^24
 ;;^UTILITY(U,$J,358.3,12757,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12757,1,1,0)
 ;;=1^140.9
 ;;^UTILITY(U,$J,358.3,12757,1,2,0)
 ;;=2^LIP CANCER,UNSPEC
 ;;^UTILITY(U,$J,358.3,12757,2)
 ;;=^266994
 ;;^UTILITY(U,$J,358.3,12758,0)
 ;;=155.0^^75^791^25
 ;;^UTILITY(U,$J,358.3,12758,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12758,1,1,0)
 ;;=1^155.0
 ;;^UTILITY(U,$J,358.3,12758,1,2,0)
 ;;=2^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,12758,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,12759,0)
 ;;=200.60^^75^791^27
 ;;^UTILITY(U,$J,358.3,12759,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12759,1,1,0)
 ;;=1^200.60
 ;;^UTILITY(U,$J,358.3,12759,1,2,0)
 ;;=2^LYMPHOMA,ANAPLASTIC LARGE CELL
 ;;^UTILITY(U,$J,358.3,12759,2)
 ;;=^335299
 ;;^UTILITY(U,$J,358.3,12760,0)
 ;;=200.20^^75^791^28
 ;;^UTILITY(U,$J,358.3,12760,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12760,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,12760,1,2,0)
 ;;=2^LYMPHOMA,BURKITT'S
 ;;^UTILITY(U,$J,358.3,12760,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,12761,0)
 ;;=201.90^^75^791^29
 ;;^UTILITY(U,$J,358.3,12761,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12761,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,12761,1,2,0)
 ;;=2^LYMPHOMA,HODGKIN'S
 ;;^UTILITY(U,$J,358.3,12761,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,12762,0)
 ;;=200.70^^75^791^30
 ;;^UTILITY(U,$J,358.3,12762,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12762,1,1,0)
 ;;=1^200.70
 ;;^UTILITY(U,$J,358.3,12762,1,2,0)
 ;;=2^LYMPHOMA,LARGE CELL
 ;;^UTILITY(U,$J,358.3,12762,2)
 ;;=^335300
 ;;^UTILITY(U,$J,358.3,12763,0)
 ;;=200.40^^75^791^31
 ;;^UTILITY(U,$J,358.3,12763,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12763,1,1,0)
 ;;=1^200.40
 ;;^UTILITY(U,$J,358.3,12763,1,2,0)
 ;;=2^LYMPHOMA,MANTLE CELL
 ;;^UTILITY(U,$J,358.3,12763,2)
 ;;=^335297
 ;;^UTILITY(U,$J,358.3,12764,0)
 ;;=200.30^^75^791^32
 ;;^UTILITY(U,$J,358.3,12764,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12764,1,1,0)
 ;;=1^200.30
 ;;^UTILITY(U,$J,358.3,12764,1,2,0)
 ;;=2^LYMPHOMA,MARGINAL ZONE
 ;;^UTILITY(U,$J,358.3,12764,2)
 ;;=^335296
 ;;^UTILITY(U,$J,358.3,12765,0)
 ;;=200.50^^75^791^34
 ;;^UTILITY(U,$J,358.3,12765,1,0)
 ;;=^358.31IA^2^2
